Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

被引：0
|
作者：
Nicola J. Lawrence
Howard Chan
Guy Toner
Martin R. Stockler
Andrew Martin
Sonia Yip
Nicole Wong
Annie Yeung
Danish Mazhar
Farzana Pashankar
Lindsay Frazier
Ray McDermott
Roderick Walker
Hsiang Tan
Ian D. Davis
Peter Grimison
机构：
[1] Australian and New Zealand Urogenital and Prostate Cancer Trials Group,Peter MacCallum Cancer Centre
[2] NHMRC Clinical Trials Centre,Concord Cancer Centre
[3] University of Melbourne,Sydney Catalyst Translational Cancer Research Centre
[4] Chris O’Brien Lifehouse,undefined
[5] Concord Repatriation General Hospital,undefined
[6] University of Sydney,undefined
[7] Cambridge University Hospitals NHS Foundation Trust,undefined
[8] Yale University School of Medicine,undefined
[9] Dana-Farber Cancer Institute and Boston Children’s Hospital,undefined
[10] Cancer Trials Ireland,undefined
[11] Lady Cilento Children’s Hospital,undefined
[12] Princess Alexandra Hospital,undefined
[13] Royal Adelaide Hospital,undefined
[14] Monash University Eastern Health Clinical School,undefined
来源：
BMC Cancer | / 18卷
关键词：
Germ cell tumours; Phase 3 trial; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 26 条
  • [1] Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
    Lawrence, Nicola J.
    Chan, Howard
    Toner, Guy
    Stockler, Martin R.
    Martin, Andrew
    Yip, Sonia
    Wong, Nicole
    Yeung, Annie
    Mazhar, Danish
    Pashankar, Farzana
    Frazier, Lindsay
    McDermott, Ray
    Walker, Roderick
    Tan, Hsiang
    Davis, Ian D.
    Grimison, Peter
    BMC CANCER, 2018, 18
  • [2] P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
    Grimison, Peter S.
    Lawrence, Nicola Jane
    Stockler, Martin R.
    Martin, Andrew James
    Yip, Sonia
    Wong, Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Grimison, Peter S.
    Lawrence, Nicola Jane
    Stockier, Martin R.
    Martin, Andrew James
    Yip, Sonia
    Wong, Nicole
    Yeung, Annie
    Friedlander, Michael
    Mazhar, Danish
    Pashankar, Farzana
    Quinn, David I.
    Walker, Rick
    Winstanley, Mark
    Nanning, Fritha J.
    Weickhardt, Andrew James
    Stevanovic, Amanda Gwendolyn
    Davis, Ian D.
    Toner, Guy C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS: THE P3BEP TRIAL (ANZUP 1302)
    Lawrence, Nicola
    Toner, Guy
    Martin, Andrew
    Stockler, Martin
    Yeung, Annie
    Wong, Nicole
    Thomson, Damien
    Gebski, Val
    Yip, Sonia
    King, Madeleine
    Friedlander, Michael
    Quinn, David
    Tan, Thean Hsiang
    Chan, Howard
    Hanning, Fritha
    Weickhardt, Andrew
    Jeffery, Mark
    Stevanovic, Amanda
    Hovey, Elizabeth
    Wyld, David
    Davis, Ian
    Grimison, Peter
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 146 - 147
  • [5] P3BEP (ANZUP 1302): An International Randomised Phase III Trial of Accelerated Versus Standard BEP Chemotherapy for Adult and Pediatric Male and Female Patients With Intermediate and Poor-Risk Metastatic Germ Cell Tumours (GCTS)
    Wong, Nicole
    Nayar, Namrata
    Lawrence, Nicola
    Stockler, Martin
    Martin, Andrew
    Yip, Sonia
    Yeung, Annie
    Friedlander, Michael
    Mazhar, Danish
    Pashankar, Farzana
    Quinn, David
    Walker, Roderick
    Winstanley, Mark
    Weickhardt, Andrew
    Hanning, Fritha
    Stevanovic, Amanda
    Davis, Ian
    Toner, Guy
    Grimison, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 168 - 168
  • [6] P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Subramaniam, Shalini
    Toner, Guy C.
    Stockler, Martin R.
    Martin, Andrew
    Pashankar, Farzana
    Tran, Ben
    Jeffery, Mark
    Mazhar, Danish
    Huddart, Robert
    Walpole, Euan
    Stevanovic, Amanda G.
    Wyld, David
    Hanning, Fritha J.
    Wheater, Matthew
    Balagtas, Jay M.
    Troon, Simon
    Birtle, Alison
    White, Jeffery
    Grimison, Peter S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 205 - 206
  • [7] P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Zebic, Danka
    Stockler, Martin R.
    Martin, Andrew
    Pashankar, Farzana
    Ben Tran
    Mazhar, Danish
    Huddart, Robert
    Wheater, Matthew
    Walpole, Euan
    Dunwoodie, Elaine
    Feldman, Darren
    Birtle, Alison
    Stevanovic, Amanda G.
    Wyld, David
    Hanning, Fritha J.
    Grimison, Peter S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 235 - 236
  • [8] P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Zebic, Danka Sinikovic
    Ben Tran
    Martin, Andrew James
    Pashankar, Farzana D.
    Mazhar, Danish
    Huddart, Robert A.
    Wheater, Matthew
    Walpole, Euan Thomas
    Dunwoodie, Elaine
    Feldman, Darren R.
    Birtle, Alison Jane
    Wyld, David
    Lawrence, Nicola Jane
    Stockler, Martin R.
    Grimison, Peter S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] THE ANZUP PHASE 3 ACCELERATED BEP TRIAL: A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS
    Long, A.
    Toner, G. C.
    Stockler, M.
    Thompson, D. B.
    Gebski, V.
    Yip, S.
    King, M.
    Friedlander, M.
    Quinn, D.
    Singhal, N.
    Roncolato, F.
    Grimison, P. S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 61 - 62
  • [10] P3BEP (ANZUP 1302): An international randomized phase Ill trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
    Zhang, Alison Yan
    Toner, Guy C.
    Lawrence, Nicola Jane
    Stockler, Martin R.
    Martin, Andrew James
    Ford, Kate
    Stevanovic, Amanda Gwendolyn
    Wyld, David
    Walpole, Euan Thomas
    Troon, Simon
    Hanning, Fritha J.
    Mallesara, Girish
    Weickhardt, Andrew James
    Birtle, Alison Jane
    Davis, Ian D.
    Grimison, Peter S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
123